SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Welcome to the POTP board, the DPP-IV company
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (42)11/18/2006 5:04:16 AM
From: rareearth42  Read Replies (2) of 90
 
rkrw,

The MCU phase 2 results were indeed positive, but I don't see how they're going to sell it for much money. Their drug is just vitamin B6. Some OTC drugs have been taken off the market when a prescription version has been approved, but they can't do that with a vitamin...everyone on total parenteral nutrition would get sick, for one example, if they didn't buy the drug off-label.

Now,some forms of vitamin D, for example, are sold without prescription as a nutritional supplement, while others are prescription. Same for vitamin B12. In fact, all forms of iv vitamins are prescription drugs. But there already exist iv formulations for vitamin B6. So MCU is just getting a label expansion for a generic iv drug. I just don't see this as a blockbuster....

RE42
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News